The institute is co-launched by University of Shanghai for Science and Technology and CAS Shanghai Advanced Research Institute and will focus on new antibody drugs. The first Director of this institute will be Richard Lerner, former President of the Scripps Research Institute, La Jolla, California

CAS press release, Oct 15, 2012